Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Mass Spectrometry Imaging Used to Process Biologic “Big Data”

By LabMedica International staff writers
Posted on 01 Dec 2014
The vast amounts of data that are generated by the latest scientific instruments are leading to significant scientific discoveries, but only when scientists can effectively process that data. More...
Big data represents both an opportunity and a challenge for scientists. This is especially the case for analytic scientists studying biologic materials using a fairly new technique known as mass spectrometry imaging (MSI). Help has arrived from a recent project, however, called Computis, which has a range of new tools for effectively processing MSI data.

MSI is a form of mass spectrometry (MS) that enables both spatial and mass spectrometric analysis by measuring the masses of compounds at specific locations on the surface of a solid sample. MSI can, therefore, construct a visual image of its chemical composition. Various MSI techniques are available, including matrix-assisted laser desorption/ionization (MALDI), secondary ion MS (SIMS) and desorption electrospray ionization (DESI), but they all generate huge amounts of data.

Although software tools are available for processing this information, they tend to be produced by the manufacturers of the MSI instruments and therefore each uses diverse data formats, making it difficult to combine and process data generated by different instruments. Computis was set up by the European Commission in 2006 to overcome this hurdle by developing a new generation of flexible and efficient tools for processing any MSI data. It involved academic and industrial teams from across Europe, including the French Atomic Energy Commission and the Swiss pharmaceutical giant Novartis (Basel, Switzerland). The project was completed in 2010 and the main outputs have now been described November 2014 in an article in the European Journal of Mass Spectrometry (EJMS).

The project members rapidly figured out that their first task should be to develop a common format for MSI data that all the other data formats could be converted into, which led to the imzML data format. This format divides MSI data into two separate files: the mass data are stored in a binary file to ensure proficient storage, while metadata such as instrumental parameters and sample details are stored in an XML file. The members also developed several tools for translating MSI data in other formats into the imzML format.

The project then developed several tools specially designed to work with the imzML format. This included two tools for processing and displaying MSI data, Data Cube Explorer and SpectViewer, and a tool called EasyReg2D for incorporating MSI data with image data from other analytic instruments, including microscopes. Furthermore, the researchers adapted an existing MSI processing tool known as BioMap to work with data in the imzML format.

According to the investigators, this project has been successful in greatly expanding the tools available for processing MSI data, helping to ensure big data becomes an opportunity for scientists instead of remaining a challenge.

Related Links:

Novartis



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.